Taichung, Taiwan

Ying-Ting Liu

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Alar Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying-Ting Liu. Retrieved from https://idiyas.com/inventor/ying-ting-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying-Ting Liu: Innovator in Pharmaceutical Formulations

Introduction

Ying-Ting Liu is an accomplished inventor based in Taichung, Taiwan. He is currently associated with Alar Pharmaceuticals, Inc., where he focuses on developing innovative pharmaceutical solutions. Despite having no granted patents to his name, Liu's contributions to the field of medicine are noteworthy.

Latest Patent Applications

Ying-Ting Liu's latest patent application is titled "Long-Acting Injectable Formulations of Ketamine Pamoate Salts." This application provides details on sustained-release pharmaceutical compositions that include a ketamine pamoate salt and a pharmaceutically acceptable carrier. The compositions encompass aqueous suspension, solution, and matrix delivery systems, which can offer sustained release for anesthesia, analgesia, or treatment of central nervous system and anti-inflammatory diseases.

Conclusion

Ying-Ting Liu is a dedicated inventor whose work in pharmaceutical formulations holds promise for advancements in medical treatments. His innovative approach to drug delivery systems may significantly impact patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…